CTNNB1 and colorectal cancer: Treatment of colorectal cancer cells with ICG-001 suppresses the association between CBP and beta-catenin and downregulates Wnt transcriptional activity in colorectal cancer cells 40, while inhibiting colorectal cancer cell proliferation and increasing apoptosis.